William P Jr Kane

CIK 1813937 · Chief Commercial Officer · last filed 2026-06-05

William P Jr Kane is a Chief Commercial Officer who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for LBRX, was dated Jun 5, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LBRX Director $28.42 $0 2 2026-06-05
Karuna Therapeutics, Inc. (KRTX) Delisted Chief Commercial Officer 8,828 $329.83 $2.91M $0 4 2024-03-18
BTAI Chief Commercial Officer $1.14 $0 2 2021-08-18

Recent Filings

8 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 LBRX Grant (A) $0 EDGAR
2025-09-12 LBRX Grant (A) $0 EDGAR
2024-03-18 Karuna Therapeutics, Inc. (KRTX) Delisted Disp (D) −13,828 -$4.56M EDGAR
2024-02-15 Karuna Therapeutics, Inc. (KRTX) Delisted Grant (A) $0 EDGAR
2023-12-29 Karuna Therapeutics, Inc. (KRTX) Delisted Tax (F) −3,828 -$1.21M EDGAR
2023-02-07 Karuna Therapeutics, Inc. (KRTX) Delisted Grant (A) +17,656 $0 EDGAR
2021-08-18 BTAI Grant (A) $0 EDGAR
2020-06-17 BTAI Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.